Comparative Analysis of Silastic Stenting in Sinus Surgery
Launched by UNIVERSITY OF BRITISH COLUMBIA · Jul 9, 2024
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at a treatment called Silastic stenting, which is used to help people heal after sinus surgery, specifically for a condition known as chronic rhinosinusitis. Silastic stents are small tubes placed in the sinus cavities to support healing. The study aims to find out how long these stents should be left in place after surgery. Some doctors believe shorter stent durations might lead to fewer complications, while others think longer durations could help with better healing.
To participate in this trial, you need to be diagnosed with chronic rhinosinusitis and require a specific type of surgery called Frontal drill-out. However, if you have had radiation treatment in the area being operated on or if you are unable to follow the study requirements, you may not be eligible. If you join the study, you'll help researchers better understand the best practices for using stents after sinus surgery, which could lead to improved care for future patients. Remember, this trial is not recruiting participants just yet, so there will be more information available soon.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients diagnosed with chronic rhinosinusitis requiring Frontal drill-out.
- Exclusion Criteria:
- • Patients unwilling or unable to comply with the study protocol.
- • Previous Radiotherapy to operated area.
About University Of British Columbia
The University of British Columbia (UBC) is a leading research institution located in Vancouver, Canada, renowned for its commitment to advancing health sciences through innovative research and education. As a prominent clinical trial sponsor, UBC leverages its interdisciplinary expertise and state-of-the-art facilities to conduct rigorous clinical studies aimed at improving patient outcomes across various medical fields. The university fosters collaborations with healthcare professionals, industry partners, and community stakeholders to translate research findings into practical applications, thereby contributing to the global advancement of medicine and public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported